Cargando…

The Role of Pharmacogenetics in Management of Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Topic, Elizabeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2003
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169143/ https://www.ncbi.nlm.nih.gov/pubmed/30302080

Ejemplares similares

Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005)

Introduction The Second FESCC Continuous Postgraduate Course in Clinical Chemistry: New Trends in Classification and Management of Cardiovascular Disease
por: Topić, Elizabeta
Publicado: (2003)

New Trends in Diagnosis, Monitoring and Management of Tumour Diseases
por: Topic, Elizabeta
Publicado: (2005)

The Eight EFCC Continuous Postgraduate Course in Clinical Chemistry: New Trends in Classification, Diagnosis and Management of Kidney Diseases
por: Topić, Elizabeta
Publicado: (2009)

The Sixth FESCC Continuous Postgraduate Course in Clinical Chemistry: New Trends in Classification, Monitoring and Management of Metabolic Syndrome
por: Topić, Elizabeta
Publicado: (2007)

Introduction First FESCC Continuousr Postgraduate Course in Clinical Chemistry: New Trends in Classification and Management of Diabetes Mellitus
por: Topić, Elizabeta
Publicado: (2002)

5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008)

Differential Diagnosis and Prognostic Markers of Stroke
por: Topic, Elizabeta
Publicado: (2004)

Editorial
por: Topić, Elizabeta
Publicado: (2006)

Genetic Aspects of Diabetes Mellitus
por: Topić, Elizabeta
Publicado: (2002)

Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases
por: Krasi, Geraldo, et al.
Publicado: (2019)

Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program
por: Papastergiou, John, et al.
Publicado: (2020)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Continuing professional development crediting system for specialists in laboratory medicine within 28 EFLM national societies
por: Topic, Elizabeta, et al.
Publicado: (2013)

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Genetics of Cardiovascular Disease
por: Stavljenic-Rukavina, Ana
Publicado: (2003)

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants
por: Mollan, Katie R, et al.
Publicado: (2017)

Strategy of Prevention of Cardiovascular Disease
por: Kovács, Gábor L., et al.
Publicado: (2003)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Rational Diagnosis of Cardiovascular Disease
por: Müller, Mathias M., et al.
Publicado: (2003)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Pharmacogenetics of lipid diseases
por: Ordovas, Jose M
Publicado: (2004)

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2017)

A pharmacogenetics approach to pain management
por: Yoshida, Kaori, et al.
Publicado: (2018)

Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis
por: Reiner, Željko
Publicado: (2003)

Psychological and psychopathological sequelae in cardiovascular acute disease
por: Caponnetto, Pasquale
Publicado: (2018)

Emergence of Echinococcus multilocularis in Central Continental Croatia: A Human Case Series and Update on Prevalence in Foxes
por: Balen Topić, Mirjana, et al.
Publicado: (2023)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide
por: Verma, Subodh, et al.
Publicado: (2021)

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia
por: de Oliveira, Fabricio Ferreira, et al.
Publicado: (2019)

Pharmacogenetics, pharmacogenomics and airway disease
por: Hall, Ian P
Publicado: (2002)

Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
por: Tanner, Rikki M., et al.
Publicado: (2011)

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
por: Dávila-Fajardo, Cristina Lucía, et al.
Publicado: (2019)

Evidence Regarding Pharmacogenetics in Pain Management and Cancer
por: Smith, D Max, et al.
Publicado: (2023)

Exploring Pharmacogenetic Testing for Hypertension Management in China
por: Zhao, Zhenping, et al.
Publicado: (2023)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
por: Pandya, Dehuti, et al.
Publicado: (2020)

Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020)

Willis-Ekbom disease is not associated with poor cardiovascular health in adults
por: Dredla, Brynn K., et al.
Publicado: (2015)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rbd959p45bu1vf0tmf42eor5po